Are current ICER thresholds outdated? Valuing medicines in the era of personalized healthcare

Percivil Melendez Carrera, Maarten Joost IJzerman

Research output: Contribution to journalArticleAcademicpeer-review

16 Citations (Scopus)
Original languageEnglish
Pages (from-to)435-437
JournalExpert review of pharmacoeconomics & outcomes research
Volume16
Issue number4
DOIs
Publication statusPublished - 6 May 2016

Keywords

  • METIS-316631
  • IR-100377

Cite this

@article{6e6d4f0b093c43ea8cb1f856436304d0,
title = "Are current ICER thresholds outdated? Valuing medicines in the era of personalized healthcare",
keywords = "METIS-316631, IR-100377",
author = "Carrera, {Percivil Melendez} and IJzerman, {Maarten Joost}",
note = "Editorial",
year = "2016",
month = "5",
day = "6",
doi = "10.1080/14737167.2016.1180980",
language = "English",
volume = "16",
pages = "435--437",
journal = "Expert review of pharmacoeconomics & outcomes research",
issn = "1473-7167",
publisher = "Taylor & Francis",
number = "4",

}

Are current ICER thresholds outdated? Valuing medicines in the era of personalized healthcare. / Carrera, Percivil Melendez; IJzerman, Maarten Joost.

In: Expert review of pharmacoeconomics & outcomes research, Vol. 16, No. 4, 06.05.2016, p. 435-437.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Are current ICER thresholds outdated? Valuing medicines in the era of personalized healthcare

AU - Carrera, Percivil Melendez

AU - IJzerman, Maarten Joost

N1 - Editorial

PY - 2016/5/6

Y1 - 2016/5/6

KW - METIS-316631

KW - IR-100377

U2 - 10.1080/14737167.2016.1180980

DO - 10.1080/14737167.2016.1180980

M3 - Article

VL - 16

SP - 435

EP - 437

JO - Expert review of pharmacoeconomics & outcomes research

JF - Expert review of pharmacoeconomics & outcomes research

SN - 1473-7167

IS - 4

ER -